MWC investigator backs COVID-19 vaccine search
27 May 2020
New Zealand scientists have already identified a number of potential COVID-19 vaccine candidates, according to Associate Professor James Ussher, MWC Associate Investigator at the University of Otago.
COVID-19 antibody testing underway in MWC labs
22 May 2020
MWC Principal Investigator Dr Nikki Moreland, Immunologist and Senior Lecturer at the University of Auckland, is working with a team of researchers on lab-based COVID-19 antibody tests in a bid to better understand the body's immune response to the virus.
MWC team awarded funding for COVID-19 research
3 May 2020
MWC researchers at the University of Auckland have been awarded Auckland Medical Research Foundation (AMRF) funding to investigate whether certain types of patent could be used for COVID-19 antiviral drug development.
MWC link to promising COVID-19 treatment
24 April 2020
Professor Peter Tyler, MWC Associate Investigator at the Ferrier Research Institute, Victoria University of Wellington, created the antiviral drug Galidesivir which is in the front-running for potential use in the treatment of COVID-19.
MWC researcher explains COVID-19 origins
14 April 2020
Dr Jemma Geoghegan, MWC researcher and Senior Lecturer in the Department of Microbiology and Immunology at the University of Otago, has given expert COVID-19 commentary that has been picked up by media in New Zealand and internationally.
COVID-19 vaccine development – comment
11 April 2020
More than 50 COVID-19 vaccines are under development in research laboratories worldwide. Much of this work is being fast-tracked. However, how likely is it that a vaccine will become available any time soon?
Take COVID-19 lockdown seriously - MWC investigator
25 March 2020
Professor Michael Baker, MWC Associate Investigator at the University of Otago's Department of Public Health, has played a leading role in providing COVID-19-related public health advice to New Zealanders.